HOME >> MEDICINE >> NEWS
Mayo Clinic researchers find evidence for traumatic cause of carpal tunnel syndrome

ROCHESTER, Minn. -- New Mayo Clinic research suggests that a shearing injury of the tissue that lines the tendons within the carpal tunnel may cause carpal tunnel syndrome, a debilitating condition of the wrist and hand. If validated by further research, Mayo's study comparing electron microscope images of carpal tunnel syndrome tissue with those from normal tissue could lead to earlier diagnosis and possibly better treatments for preventing or reversing carpal tunnel syndrome.

The study appears in the November issue of Plastic and Reconstructive Surgery (http://www.plasreconsurg.com/pt/re/prs/currenttoc.htm;jsessionid=FLyBWMS3hFd55wPBnpD339LCnXps4g1trvBJ0Qc6HkNFlhkzLLnK!-1434154485!-949856145!8091!-1).

In the study, the Mayo researchers present data which suggest that the carpal tunnel syndrome disease process begins with a shearing injury. As the injury heals, the resulting scar tissue impedes the sliding motion of the tendon, compresses the median nerve, cuts off the nerve's blood supply and eventually leads to the pressure buildup characteristic of carpal tunnel syndrome, a condition that affects an estimated five percent of adults. The end result of this process is the familiar carpal tunnel syndrome symptoms of hand pain, numbness and tingling associated with carpal tunnel syndrome.

Significance of the Mayo Clinic Research

The Mayo research offers an explanation for the cause of carpal tunnel syndrome. Although carpal tunnel syndrome is a well-recognized condition, in most cases the specific cause has been unknown. What is well known is that a pressure buildup in the carpal tunnel affects the circulation nourishing the nerves, which can lead to pain, numbness and tingling. The question Mayo researchers explored was: What leads to the pressure buildup? Their
'"/>

Contact: Amy Reyes
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
9-Nov-2006


Page: 1 2

Related medicine news :

1. Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer
2. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
5. New Mayo Clinic MRI technology enables noninvasive liver diagnoses
6. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
7. Elsevier launches the Clinics on ScienceDirect
8. Clinical guidelines for blood conservation during cardiac procedures developed
9. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
10. Mayo Clinic research in cardiovascular disease presented at Experimental Biology 2007
11. Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression

Post Your Comments:
(Date:5/20/2013)... May 20, 2013 The Multiple System ... the launch of its new Multiple System Atrophy ... few years, The MSA Coalition’s grass roots fundraising has ... mission beyond patient/caregiver support to now include education, advocacy ... all donations received by The Coalition go directly into ...
(Date:5/20/2013)... 2013 Gilman Law LLP, a leading ... Byetta lawsuits, is troubled by a new study that ... similar type 2 diabetes drugs are growing. The ... (ISMP), found that 71 Byetta pancreatic cancer reports had ... (FDA) as of June 30, 2012. Overall, ...
(Date:5/20/2013)... Dalton, Georgia (PRWEB) May 20, 2013 ... fields, has significantly expanded its presence in the Midwest ... office in Kansas City, Missouri. Sporturf Midwest is ... focus on Iowa, Nebraska, Missouri and Kansas. , ... Sporturf has not really been in before,” noted Shonk. ...
(Date:5/20/2013)... May 20, 2013 Headquartered in New ... Levy Phillips & Konigsberg LLP (“LPK”) has recently ... Plains, New York. LPK will better serve people suffering ... Valley, including Westchester, Putnam, Rockland, Orange, and Dutchess counties. ... by asbestos-related diseases throughout New York, New Jersey, and ...
(Date:5/20/2013)... VA (PRWEB) May 20, 2013 Orthopaedic ... successfully performed a procedure using SpineFrontier’s FacetFuse Screw System ... System. The operation took place on Tuesday, April ... Newport News, VA. The surgery was a facet ... year-old, female patient. , Dr. Carlson described the case, ...
Breaking Medicine News(10 mins):Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 2Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 3Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 4Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 5Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 2Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 3Health News:Sporturf Expands into the Midwestern U.S. 2Health News:Westchester Mesothelioma Lawyers Open Office in White Plains, New York 2Health News:Westchester Mesothelioma Lawyers Open Office in White Plains, New York 3Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 2Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 3
(Date:5/20/2013)... , May 20, 2013 Sequent Medical, Inc. ... the SL ("Single Layer") family of WEB ® ... of these new models in select neurovascular centers in ... superior navigability that will enable physicians to treat a ... The SL configurations are made possible by further ...
(Date:5/20/2013)... , Kalifornien, 20. Mai 2013 /PRNewswire/ ... dass das Unternehmen die CE-Kennzeichnung für die ... Embolisation von Aneurysmen erhalten hat. Das Unternehmen ... bereits mit der kontrollierten Einführung dieser neuen ... die SL-Produktfamilie auch ein verbessertes Handling, das ...
(Date:5/20/2013)... --  Life Technologies Corporation (NASDAQ: LIFE ... and 3500xL Dx Genetic Analyzers have been approved by ... Mexico for diagnostic use.  The ... to serve the clinical end market in ... -based solutions.  The Applied Biosystems™ 3500 ...
Breaking Medicine Technology:Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3
Cached News: